Zanubrutinib (Brukinsa®) Patient Selection and Management – 2

In an effort to promote higher quality patient care, NCODA created the NCODA Positive Quality Intervention (PQI) as a peer-reviewed clinical guidance resource for healthcare providers. By providing Quality Standards and effective practices around a specific aspect of cancer care, PQIs equip the entire multidisciplinary care team with a sophisticated yet concise resource for managing patients receiving oral or IV oncolytics. This PQI in Action is a follow-up to the Zanubrutinib (BRUKINSA®) Patient Selection and Management PQI and explores how the medically integrated teams at Arizona Oncology, Carolina Blood & Cancer Care Associates, and Vanderbilt-Ingram Cancer Center incorporate the information found in the PQIs as part of their daily workflow. This article will discuss how utilizing the Zanubrutinib (BRUKINSA®) Patient Selection and Management PQI elevates patient care.